Despite decades of public health messaging, Canadians are spending more time in the sun and using less sun protection – raising alarms among researchers as melanoma cases continue to climb.
Melanoma News
Leading Cancer Organizations Express Profound Concern Over Proposed Elimination of CDC’s Cancer Prevention Division
On behalf of the millions of Americans living with cancer and at risk for being diagnosed, as well as health care providers, researchers, advocates and their communities, we express our profound disappointment and grave concern regarding the proposed elimination of the Centers for Disease Control and Prevention’s Division of Cancer Prevention and Control (DCPC) in the President’s FY2026 discretionary funding request.
The State of Melanoma Care: Advances, Access, and the Road Ahead
In case you missed it, this week we had news about abrocitinib’s flexible dosing for atopic dermatitis, plant-derived exosomes in regenerative skin care, psychosocial support in hidradenitis suppurativa care, and more.
ctDNA After Surgery Identified Patients at High Risk for Early Recurrence in Stage III Melanoma Trial
Measurements of circulating tumor DNA (ctDNA) before adjuvant targeted therapy and during follow-up identified patients with stage III melanoma at high risk for early disease recurrence, according to results of an analysis of patients from the COMBI-AD trial published recently in The Lancet Oncology.